Acadia Healthcare Company, Inc. has appointed Michael J. Fucci to its Board of Directors, a move that broadens the board to nine members and strengthens corporate governance as the behavioral health provider pursues growth. The company confirmed the appointment as effective immediately, with eight of the nine directors designated as independent. (Acadia board page: https://www.acadiahealthcare.com/investors/board-directors/)

The selection of Mike Fucci, Acadia Healthcare officials said, brings decades of leadership in professional services and human capital transformation to a company operating a national network of behavioral health facilities. As of June 30, 2020, Acadia operated 589 facilities with approximately 18,200 beds across 40 states, the United Kingdom and Puerto Rico, providing services in inpatient psychiatric hospitals, specialty treatment centers, residential programs and outpatient clinics.

Fucci retired in September 2020 after a nearly three-decade career at Deloitte. He served as Chairman Emeritus of Deloitte U.S. and as Executive Chairman from 2015 to 2019. Earlier, he was Chief Operating Officer of Deloitte Consulting from 2009 to 2015 and held leadership roles beginning in 2003. His responsibilities at Deloitte included governance and operational oversight of strategy, leadership succession, risk mitigation, talent development and executive performance and compensation. (Fucci profiles: LinkedIn https://www.linkedin.com/in/fuccimike, BizJournals https://www.bizjournals.com/nashville/potmsearch/detail/submission/6554120/Mike_Fucci, Crunchbase https://www.crunchbase.com/person/michael-fucci-16a6, XCancel https://xcancel.com/fucci_mike)

During his tenure at Deloitte, Fucci joined the Deloitte U.S. Board of Directors in 2013, where he led the risk and regulatory committee and participated in the committee responsible for evaluating performance and recommending compensation for elected leaders. In 2015 he joined the Deloitte Global Board, serving on the global governance committee and the compensation and evaluation committee. He also established and co-chaired the Board Leadership Forum, a coalition of Fortune 500 board chairs and lead directors focused on trends and governance best practices, and chaired the Deloitte Foundation, which supports education initiatives.

Board leadership at Acadia emphasized that Fucci’s background in organizational strategy and human resource transformation aligns with the company’s priorities. His experience advising large enterprises on corporate talent strategies and risk management is viewed as a complement to the existing board expertise, particularly as Acadia navigates heightened demand for behavioral health services amid ongoing public health and economic challenges.

Responding to the appointment, Fucci expressed a commitment to supporting Acadia’s role in behavioral healthcare delivery during a critical period of need. His addition to the board follows a broader trend of health care companies recruiting governance talent with deep experience in risk oversight, human capital and organizational change.

Acadia Healthcare, traded on NASDAQ under the ticker ACHC, operates across multiple care settings and continues to pursue strategic initiatives to expand services and enhance patient care. The company’s decision to add an experienced practitioner of corporate governance reflects an intent to bolster oversight and stewardship as it executes long-term growth plans and seeks to deliver value for stakeholders. (Board and director information: https://www.acadiahealthcare.com/investors/board-directors/)